Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Medtronic
UBS
Cantor Fitzgerald
Dow
Queensland Health
US Department of Justice
Mallinckrodt
Baxter

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084143

« Back to Dashboard

NDA 084143 describes SODIUM SULFACETAMIDE, which is a drug marketed by Akorn and Sola Barnes Hind and is included in five NDAs. Additional details are available on the SODIUM SULFACETAMIDE profile page.

The generic ingredient in SODIUM SULFACETAMIDE is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 084143
Tradename:SODIUM SULFACETAMIDE
Applicant:Sola Barnes Hind
Ingredient:sulfacetamide sodium
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084143

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Cipla
Julphar
Covington
Accenture
Queensland Health
Healthtrust
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.